PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1671922
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1671922
The global glucuronolactone market is estimated to be valued at USD 258.3 Mn in 2025 and is expected to reach USD 406.7 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 258.3 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 6.70% | 2032 Value Projection: | USD 406.7 Mn |
Glucuronolactone is a key substance involved in connective tissue metabolism and antioxidant activity in the human body. As a major player in maintaining collagen levels, it helps support joint and skin health from within. It is found naturally in the human body as well as various foods including citrus fruits and tomatoes. The global glucuronolactone market has been growing in response to increasing demand for nutraceuticals and supplements that support general wellness and recovery from exercise or injury. Consumers are more aware of how certain naturally-derived compounds can optimize their health and are looking to dietary supplements as a convenient and effective option.
The major drivers fueling the growth of the global glucuronolactone market include increasing health consciousness and proactive approaches to healthcare, expansion of the nutraceuticals industry, and rising prioritization of physical fitness globally. People are seeking natural remedies to support joint health as the population ages. Additionally, growing participation in sports and other rigorous physical activities is boosting demand for supplements that speed recovery time. However, the market potential is constrained by the availability of cheaper substitutes and options for meeting nutritional needs through a balanced diet. Opportunities lie in further research validating glucuronolactone's benefits and developing innovative delivery formats.
This report provides in-depth analysis of the global glucuronolactone market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global glucuronolactone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Hubei Yichang Humanwell Pharmaceutical Co., Ltd., Hunan Jinjing Chemical Co., Ltd., Achem Technology Co., Ltd., Chengdu Ailin Biotechnology Co., Ltd., Jiangsu Wuzhong Chemical Co., Ltd., Ginkgo BioWorks, Inc., Hangzhou Tianlong Biotechnology Co., Ltd., Kyowa Hakko Bio Co., Ltd., Shijiazhuang Shuanghuan Chemical Co., Ltd., Dancheng County Shuangta Food Co., Ltd., Suzhou Sunway Pharmaceutical Co., Ltd., Jiangsu Yangnong Chemical Group Co., Ltd., Zhejiang Jianfeng Chemical Co., Ltd., and Jiangxi Shunfeng Biotechnology Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global glucuronolactone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts